SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) saw a significant drop in short interest in August. As of August 31st, there was short interest totalling 742,500 shares, a drop of 22.3% from the August 15th total of 955,900 shares. Based on an average daily trading volume, of 375,000 shares, the days-to-cover ratio is presently 2.0 […]
Royce & Associates LP grew its position in shares of SI-BONE, Inc. (NASDAQ:SIBN – Free Report) by 37.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 132,000 shares of the company’s stock after acquiring an additional 36,000 shares […]
SI-Bone s iFuse Bedrock Granite spine implants are compatible with certain CD Horizon Solera 5.5mm and 6.0mm rods from Medtronic, according to a Sept. 6 news release.
Cantor Fitzgerald restated their overweight rating on shares of SI-BONE (NASDAQ:SIBN – Free Report) in a research report released on Tuesday, Benzinga reports. Cantor Fitzgerald currently has a $30.00 price target on the stock. Several other equities analysts have also recently issued reports on the company. Needham & Company LLC reissued a buy rating and […]
Shares of SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) have been given a consensus recommendation of “Buy” by the seven ratings firms that are presently covering the company, Marketbeat reports. Seven investment analysts have rated the stock with a buy rating. The average twelve-month price objective among brokers that have issued a report on the […]